Persistency patterns of treatment with rivastigmine versus donepezil in a medicaid population

被引：0
|
作者：
Singh, G
Thomas, S
Bharathi, V
Wong, K
Mithal, A
机构：
来源：
ANNALS OF NEUROLOGY | 2004年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S5 / S6
页数：2
相关论文
共 50 条
  • [1] Treatment persistency with rivastigmine and donepezil in a large state Medicaid program
    Singh, G
    Thomas, SK
    Arcona, S
    Lingala, V
    Mithal, A
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2005, 53 (07) : 1269 - 1270
  • [2] Donepezil versus rivastigmine utilization patterns in a retrospective claims analysis
    Shah, S
    Broderick, W
    Solis, A
    McRae, V
    Mastey, V
    VALUE IN HEALTH, 2003, 6 (03) : 280 - 281
  • [3] Drug persistency of two cholinesterase inhibitors - Rivastigmine versus donepezil in elderly patients with Alzheimer's disease
    Suh, DC
    Thomas, SK
    Valiyeva, E
    Arcona, S
    Vo, L
    DRUGS & AGING, 2005, 22 (08) : 695 - 707
  • [4] Donepezil versus rivastigmine utilization patterns in a retrospective claims analysis.
    Broderick, WC
    Solis, A
    McRae, T
    Mastey, V
    Shah, S
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2003, 51 (04) : S121 - S122
  • [5] Drug persistency of two cholinesterase inhibitors - Rivastigmine versus donepezil among elderly patients with Alzheimer's disease
    Suh, DC
    Thomas, SK
    Valiyeva, E
    Arcona, S
    Vo, L
    VALUE IN HEALTH, 2005, 8 (03) : 315 - 316
  • [6] A COMPARISON OF TREATMENT PATTERNS AND COSTS FOR SUBJECTS NEWLY TREATED WITH DONEPEZIL VERSUS THOSE NEWLY TREATED WITH GALANTAMINE OR RIVASTIGMINE
    Ye, X.
    Roberts, C. S.
    Hoffman, D. L.
    Liu, F.
    Iorga, S. R.
    VALUE IN HEALTH, 2009, 12 (07) : A355 - A355
  • [7] Long-term treatment with donepezil and rivastigmine treatment:: The effect on cognition
    Borkowska, A
    Ziókowska, M
    Pilaczyñska, E
    Kêpa, A
    Rybakowski, J
    INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 248 - 249
  • [8] Donepezil versus rivastigmine tolerability study in dementia with Lewy bodies and Alzheimer's disease
    Magierski, R.
    Sobow, T.
    Kloszewska, I.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S62 - S62
  • [9] Risk of rhabdomyolysis with donepezil compared with rivastigmine or galantamine: a population-based cohort study
    Fleet, Jamie L.
    McArthur, Eric
    Patel, Aakil
    Weir, Matthew A.
    Montero-Odasso, Manuel
    Garg, Amit X.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2019, 191 (37) : E1018 - E1024
  • [10] An assessment of Parkinson's disease medication treatment patterns in the Medicaid population
    Johnsrud, Michael
    Richards, Kristin
    Arcona, Steve
    Sasane, Rahul
    Leoni, Matthew
    CLINICAL PARKINSONISM & RELATED DISORDERS, 2021, 5
12345